The hla typing market was valued at USD 1.30 billion in 2025, projected to reach USD 1.39 billion in 2026, and is forecast to expand to USD 2.65 billion by 2036 at a 6.70% CAGR. As per FMI, the incremental opportunity across the forecast period amounts to USD 1.27 billion, reflecting a steady expansion trajectory shaped by evolving end-use requirements and shifting procurement patterns across global supply chains.
Expanding organ and stem cell transplantation volumes, growing pharmacogenomic testing adoption, and advancing molecular assay precision are driving procurement growth for human leukocyte antigen (HLA) typing products across transplant centers, research laboratories, and commercial service providers. Next-generation sequencing-based HLA typing is progressively displacing lower-resolution serological methods as transplant programs mandate allele-level resolution to optimize donor-recipient matching and reduce graft rejection risk. As per FMI, the molecular assay technique commands the leading share as sequenced-based and PCR-based HLA typing deliver the allele-level resolution required by current transplant matching algorithms.
| Metric | Details |
|---|---|
| Industry Size (2026) | USD 1.39 Billion |
| Industry Value (2036) | USD 2.65 Billion |
| CAGR (2026-2036) | 6.70% |
Source: Future Market Insights, 2026
Regional demand for HLA typing products reflects the geographic distribution of transplant program activity, donor registry size, and pharmacogenomic research investment. China at 7.1% CAGR, USA at 6.9% CAGR, Japan at 6.5% CAGR, UK at 5.8% CAGR, South Korea at 4.7% CAGR. China leads growth through expanding organ transplant program capacity and national donor registry development. India follows on the strength of growing stem cell transplant volumes and diagnostic laboratory modernization. Germany sustains growth through its position as a major bone marrow donor registry operator and precision transplant medicine center. The United States advances through large-scale transplant program procurement and pharmacogenomic research funding. The United Kingdom maintains growth through NHS transplant service modernization and research council investment.
Based on FMI's report, the hla typing market is expected to create an incremental opportunity of USD 1.27 billion between 2026 and 2036. FMI analysts project that end-use procurement patterns and regional supply chain dynamics will shape the distribution of this opportunity across segments and geographies.
HLA typing is the laboratory process of identifying human leukocyte antigen alleles on an individual's cells, primarily for organ and stem cell transplant donor-recipient matching, disease association research, and pharmacogenomic testing. Product categories include reagents and consumables, instruments (sequencers, PCR systems), and software and services. Typing techniques span molecular assays (sequence-based typing, PCR-SSP, PCR-SSO) and non-molecular assays (serological methods). These products are deployed across commercial typing service providers, transplant centers, hospitals, research laboratories, and academic institutes.
Future Market Insights analysis captures the complete addressable consumption base across all major producing and consuming regions, covering the forecast period from 2026 to 2036.
Market scope includes HLA typing reagents, instruments, and software/services across molecular and non-molecular techniques for diagnostic and research applications. The assessment covers global and regional market sizes, forecast period 2026 to 2036, and segment breakdowns by product type, application, technique, end user, and region.
The scope excludes general immunology reagents, flow cytometry instruments not dedicated to HLA analysis, organ preservation solutions, and transplant surgical equipment. Donor recruitment and registry administration costs are not included.
The global HLA typing market has three categories based on the type of products - instruments, reagents and consumables, and software and services. The instruments segment is perfect for organ transplantation procedures of the vital organs.
The instruments segment held a CAGR of 8.0% from 2021 to 2026. The software and services segment is anticipated to catch up to the instruments segment in terms of value as organ transplantation, disease diagnosis, and personalized medicines expand during the research period. In the upcoming decade, the instruments segment has been supposed to dominate the market, according to a global CAGR of 6.5%.
| Top Product | Instruments |
|---|---|
| CAGR % | 8.0% CAGR |
| CAGR % 2026 to End of Forecast (2036) | 6.5% CAGR |
During the forecast period, the global HLA typing transplant market is segmented into diagnostics and research, with the diagnostics segment accounting for a leading market share in 2026, with a CAGR of 7.7%. This can be attributed to the trend among hospitals and transplant centers to outsource laboratory services, as well as the increase in diagnostics laboratories merging.
Hospitals and transplant centers collaborate with diagnostic labs to perform diagnostic tests that can diagnose diseases such as Behcet's disease, rheumatoid arthritis, and narcolepsy, which can accelerate the market for HLA typing. The research segment is expected to experience significant growth during the forecast period.
| Top Application | Diagnosis |
|---|---|
| CAGR % | 7.7% CAGR |
| CAGR % 2026 to End of Forecast (2036) | 6.3% CAGR |
.webp "Top Country Growth Comparison Hla Typing Market Cagr (2026 2036)")
The HLA typing market in the United States generated revenue of USD 2.4 million in 2036. The market may grow significantly in the coming years, with an expected CAGR of 6.9% from 2026 to 2036. The United States dominates the market due to the rise in demand for organ transplants and the government's support to encourage growth in programs for organ donation and transplantation.
| Country | United States |
|---|---|
| CAGR (2021 to 2026) | 8.7% |
| CAGR (2026 to 2036) | 6.9% |
The United Kingdom is expected to dominate the market growth during the forecast period, thanks to the high adoption of advanced technologies and the increasing prevalence of the disease. These factors are expected to drive the development of the regional market in the United Kingdom. The HLA typing market in the United Kingdom is anticipated to deliver a market share of 69.3 million with a CAGR of 5.8% in the upcoming decade.
| Country | United Kingdom |
|---|---|
| CAGR (2021 to 2026) | 6.6% |
| CAGR (2026 to 2036) | 5.8% |
By 2026, the HLA typing industry in China is expected to experience a significant growth rate of 9.5%. The demand for HLA typing is predicted to continuously increase, with a compound annual growth rate of 7.1% over the next ten years. This growth is attributed to the improved infrastructure of healthcare facilities, expanding economic factors, and well-designed reimbursement policies, which are having a positive impact on the development of the market.
| Country | China |
|---|---|
| CAGR (2021 to 2026) | 9.5% |
| CAGR (2026 to 2036) | 7.1% |
In the upcoming years, the market for HLA typing in Japan is expected to experience significant growth. This is attributed to the development of technical and healthcare sectors in producing provinces. It is anticipated that the demand for HLA typing in Japan is likely to register a growth of 7.6% between 2026 and 2036. The healthcare sector's growing demand for HLA typing is expected to propel market growth in the next decade.
| Country | Japan |
|---|---|
| CAGR (2021 to 2026) | 9.3% |
| CAGR (2026 to 2036) | 6.5% |
The market for HLA typing in South Korea is expected to evolve rapidly in the coming years. This is due to the development of the technical and healthcare sectors in developing provinces. The demand for HLA typing in South Korea is projected to record a CAGR of around 4.7% from 2026 to 2036. The healthcare sector's increasing need for HLA typing is expected to drive market growth in the next decade.
| Country | South Korea |
|---|---|
| CAGR | 5.2% |
| CAGR (2026 to 2036) | 4.7% |
HLA typing is increasingly essential in healthcare, providing benefits such as improved outcomes in organ transplantation, personalized medicine, better diagnosis and treatment of diseases, and scientific research opportunities. Key players in the market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Omixon Inc., GenDx, and Illumina Inc., which use organic and inorganic growth strategies to expand their consumer base.
| Metric | Value |
|---|---|
| Quantitative Units | USD 1.39 Billion to USD 2.65 Billion, at a CAGR of 6.70% |
| Market Definition | HLA typing is the laboratory process of identifying human leukocyte antigen alleles on an individual's cells, primarily for organ and stem cell transplant donor-recipient matching, disease association research, and pharmacogenomic testing. Product categories include reagents and consumables, instruments (sequencers, PCR systems), and software and services. |
| Segmentation | Product Type: Reagents & Consumables, Instruments, Software & Services; Application: Diagnosis, Research; Technique: Molecular Assay, Sequenced-based Molecular Assay, Non-molecular Assay; End User: Commercial Service Providers, Hospitals, Transplant Centers, Research Labs, Academic Institutes |
| Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa |
| Countries Covered | China, USA, Japan, UK, South Korea, and 40 plus countries |
| Key Companies Profiled | Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Omixon Inc., GenDx, Illumina Inc., F.Hoffmann-La Roche Ltd., Immucor, Inc., bioMerieux S.A., CareDx, Inc., Hologic, Inc., Olerup International AB |
| Forecast Period | 2026 to 2036 |
| Approach | Forecasting models apply a bottom-up methodology starting with regional utilization metrics and projecting adoption rates against demand drivers and regulatory frameworks. |
This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with primary research documentation.
How large is the demand for HLA Typing in the global market in 2026?
Demand for HLA Typing in the global market is estimated to be valued at USD 1.39 billion in 2026.
What will be the market size of HLA Typing in the global market by 2036?
Market size for HLA Typing is projected to reach USD 2.65 billion by 2036.
What is the expected demand growth for HLA Typing between 2026 and 2036?
Demand for HLA Typing is expected to grow at a CAGR of 6.70% between 2026 and 2036.
Which Product Type is poised to lead global sales by 2026?
Reagents & Consumables accounts for 46.7% share in 2026 based on structural demand factors and procurement concentration patterns.
What is driving demand in China?
China leads growth at 7.1% CAGR through 2036, driven by expanding capacity and end-use procurement volumes.
What is USA's growth outlook in this report?
USA is projected to grow at a CAGR of 6.9% during 2026 to 2036.
What is HLA Typing and what is it mainly used for?
HLA typing is the laboratory process of identifying human leukocyte antigen alleles on an individual's cells, primarily for organ and stem cell transplant donor-recipient matching, disease association research, and pharmacogenomic testing. Product categories include reagents and consumables, instruments (sequencers, PCR systems), and software and services.
How does FMI build and validate the forecast?
Forecasting models apply a bottom-up methodology starting with regional utilization metrics and cross-validate projections against industry statistics and company guidance.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
HLA Typing Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
